Socati, an Austin-based company, is becoming a major player in the booming and innovative industry of CBD products. The company is currently producing CBD broad-spectrum oil, a newly designed product that is rich in CBD and other minor cannabinoids, along with water-soluble CBD, both of which are supplied directly to CPG organizations for manufacturing.
The biotechnology and pharmaceutical company began operating in 2018 and has since been producing CBD-infused products that have disrupted the entire industry. The inception of the company came at a time when hemp and CBD businesses had grown in popularity and the implementation of various legal strategies guided the production and use of these ingredients.
Companies in the CBD space are captivating investors within short periods of time with their unique cannabinoid products. Other businesses have already allowed the commercial use of these products, indicating that others may soon follow in their footsteps. As a result, the demand for CBG, CBD, and other cannabinoid products will likely increase.
Socati, in particular, has attracted many investors willing to invest in the company and its new method of producing broad-spectrum oil cannabinoid products. Investors believe that the cannabinoid sector is still at the inception stage, which is the most desirable time to get involved.
Investors are putting money behind businesses in this sector with the notion that they will soon receive a return on investment based on current industry trends. The biotechnology company raised $42 million from its first two rounds of funding, clearly indicating the growing interest in cannabinoid products.
Socati has created a buzz in the industry by producing broad-spectrum products that are attractive to millions of consumers around the world. The company has effectively eliminated the perception that cannabinoid products are limited to a small target audience. In light of this newfound acceptance, it is now more convenient for companies to produce products that have the potential to dominate the market.
Along with the use of advanced cannabinoid extraction in the drug manufacturing industry, these innovative techniques can be utilized as high-quality raw materials in the development of various other products.
The company is presently using new extraction techniques that are revolutionizing the industry, including chromatographic processes. While the future is not certain, the cannabinoid sector is expected to grow by more than $20 billion in the next five years.